SAMPLIX ApS
Desconocido
Cellularity: The critical shift to single-cell formats in functional analyses of living cells
SAMPLIX ApS
tramitó un
HORIZON EUROPE:
HORIZON-EIC-2023-ACCELERATOR-01
The incredible potential of cell and immune therapy (CIT) is limited by technical challenges related to the standard analysis of immune cell...
2023-07-14 - 2025-07-31 | Financiado
2023-07-14 - 2025-07-31 | Financiado
IMPACT: Improving DNA Analysis for Correct Healthcare
SAMPLIX ApS
tramitó un
H2020:
H2020-EIC-SMEInst-2018-2020
Over the past 10 years DNA sequencing has revolutionized how we apply genetics in personalized healthcare, diagnosis and drug development de...
2019-04-12 - 2021-04-30 | Financiado
2019-04-12 - 2021-04-30 | Financiado
* No se disponen de datos de la empresa actual.